A new instrument for assessing quality of life in atopic dermatitis: International development of the Quality of Life Index for Atopic Dermatitis (QoLIAD)

British Journal of Dermatology

Volumn 150, Issue 2, 2004, Pages 274-283

  Whalley, D ^a   Mckenna, S P ^a   Dewar, A L ^a   Erdman, R A ^b   Kohlmann, T ^c   Niero, M ^d   Cook, S A ^a   Crickx, B ^e   Herdman, M J ^f   Frech, F ^g   Van Assche, D ^g  

^a GALEN RESEARCH   (United Kingdom)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY OF VERONA   (Italy)

^e Section of Radiology   (France)

^f 3D Health Research   (Spain)

^g NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Atopic dermatitis; Eczema; QoLIAD; Quality of life; Questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; EMOTION; EMOTIONAL STABILITY; FEMALE; FRANCE; GERMANY; HEALTH SURVEY; HUMAN; INTERNATIONAL COOPERATION; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MENTAL HEALTH; METHODOLOGY; NETHERLANDS; PATIENT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; QUALITATIVE ANALYSIS; QUALITY OF LIFE; RELIABILITY; SAMPLE SIZE; SELF ESTEEM; STIMULATION; UNITED KINGDOM; UNITED STATES; VALIDATION PROCESS; WELLBEING;

ADOLESCENT; ADULT; AGED; DERMATITIS, ATOPIC; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 12144287798     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05783.x     Document Type: Article

References (27)

1. Hunter JA, Herd RM. Recent advances in atopic dermatitis. Q J Med 1994; 87: 323-7.
2. Shultz Larsen F, Holm NV, Henningsen K. Atopic dermatitis. A genetic epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986; 15: 487-94.
3. Papadopoulos L, Bor R, eds. Psychological Approaches to Dermatology. Leicester: BPS Books, 1999.
4. Finlay AY. Quality of life impairment in atopic dermatitis and psoriasis. Clin Exp Persp Sandimmun Ther 1992; 2: 10-11.
5. Chren M, Lasek RJ, Quinn LM et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-13.
6. Morgan M, McCreedy R, Simpson J et al. Dermatology quality of life scales: a measure of the impact of skin diseases. Br J Dermatol 1997; 136: 202-6.
7. Eun HC, Finlay AY. Measurement of atopic dermatitis disability. Ann Dermatol 1990; 2: 9-12.
8. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37: 41-50.
9. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16.
10. Whiteneck GG. Measuring what matters: key rehabilitation outcomes. Arch Phys Med Rehabil 1994; 75: 1073-6.
11. Heinemann AW, Whiteneck GG. Relationships among impairment, disability, handicap and life satisfaction in persons with traumatic brain injury. J Head Trauma Rehabil 1995; 10: 54-63.
12. McKenna SP, Whalley D, Doward LC. Which outcomes are important in schizophrenia. Int J Methods Psychiatr Res 2000; 9 (Suppl. 1): S58-67.
13. Spilker B. Introduction. In: Quality of Life Assessments in Clinical Trials (Spilker B, ed.). New York: Raven Press, 1996: 11-23.
14. Koch T. Life quality vs the 'quality of life': assumptions underlying prospective quality of life instruments in health care planning. Soc Sci Med 2000; 51: 419-27.
15. Parmenter TR. Quality of life as a concept and measurable entity. Social Indicators Res 1994; 33: 9-46.
16. Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy 1992; 22: 307-19.
17. McKenna SP, Hunt SM. A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS. Health Policy 1992; 22: 321-30.
18. Holmes SJ, McKenna SP, Doward LC et al. Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency. Endocrinol Metab 1995; 2: 63-9.
19. McKenna SP, Doward LC, Mackenzie Davey K. The development and psychometric properties of the MSQOL: a migraine-specific quality-of-life instrument. Clin Drug Invest 1998; 15: 413-23.
20. Wagner TH, Patrick DL, McKenna SP et al. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1996; 5: 443-9.
21. de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 1997; 36: 878-83.
22. Doward LC, Spoorenberg A, Cook SA et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62: 20-6.
23. Hunt SM, Alonso J, Bucquet D et al. Cross-cultural adaptation of health measures. Health Policy 1991; 19: 33-44.
24. Andrich D. Rasch Models for Measurement. London: Sage Publications, 1988.
25. Weiner EA, Stewart BJ. Assessing Individuals. Boston: Little Brown. 1984.
26. Streiner D, Norman G. Health Measurement Scales, 2nd edn. Oxford: Oxford University Press, 1995.
27. Niero M, Martin M, Finger T et al. A new approach to multicultural item generation in the development of two obesity-specific measures: the Obesity and Weight Loss Quality of Life (OWLQOL) questionnaire and the Weight-Related Symptom Measure (WRSM). Clin Ther 2002; 24: 690-700.